The independent t-test comparison revealed a significant difference between females and males in SDS/SAS scores, consistent with previous studies (12, 13). This finding supports the notion that females are at a higher risk of depression, which aligns with our study's sample composition, primarily consisting of young females, many of whom were in the pre-pubertal stage.
The observed difference between the depression group and the control group in HF could be attributed to the modulation of parasympathetic system by depression symptoms (14). Since HF serves as an indicator of parasympathetic modulation, a lower HF value indicates modulation resulting from abnormal parasympathetic function, which influences the pathological processes of various diseases, including MDD (15).
Supporting our findings, a recent meta-analysis (16) investigated children and adolescents (n = 2625) and consistently reported lower HF values in individuals with depression. Another study (17) has similarly revealed that depressed subjects exhibit lower HF values during rest conditions and show reduced inhibition during task conditions.
The results from the animal experiment are consistent with the clinical findings, where the control group exhibited higher HF values compared to the model group. Moreover, the clinical results indicated that the control group had higher HF values than the depression group, further demonstrating that lower HF values can distinguish the model group from the control group.
However, limitations, such as sample size variations, variations in stressors employed, and differences in HRV recording methodologies, may explain the divergent outcomes between the clinical and animal experiments. These limitations warrant further research to confirm and elucidate these findings.